Chest
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Guest Access | Sign In via User Name/Password
This Article
Right arrow Full Text Free
Right arrow Full Text (PDF) Free
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Article Archive
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Bertolino, P.
Right arrow Articles by ten Dijke, P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Bertolino, P.
Right arrow Articles by ten Dijke, P.
(Chest. 2005;128:585S-590S.)
© 2005 American College of Chest Physicians

Transforming Growth Factor-ß Signal Transduction in Angiogenesis and Vascular Disorders*

Philippe Bertolino, PhD; Martine Deckers, PhD; Franck Lebrin, PhD and Peter ten Dijke, PhD

* From the Division of Cellular Biochemistry, The Netherlands Cancer Institute, Amsterdam, The Netherlands.

Correspondence to: Peter ten Dijke, PhD, Division of Cellular Biochemistry, The Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX Amsterdam, The Netherlands; e-mail: p.t.dijke{at}nki.nl

Transforming growth factor (TGF)-ß is a multifunctional protein that initiates its diverse cellular responses by binding to and activating specific type I and type II serine/threonine kinase receptors. TGF-ß can act as a regulator of proliferation, migration, survival, differentiation, and extracellular matrix synthesis in endothelial cells and vascular smooth muscle cells, as well as in the maintenance of vascular homeostasis. Importantly, genetic studies in humans have revealed the pivotal role of TGF-ß as well as its signaling components in angiogenesis. Mutations in two TGF-ß receptors (ie, the activin receptor-like kinase (ALK) 1 and the accessory TGF-ß receptor endoglin) have been linked to vascular disorders named hereditary hemorrhagic telangiectasia. In addition, knockout mice for the different components of the TGF-ß signaling pathway have shown that TGF-ß is indispensable for angiogenesis. Recent studies have revealed that TGF-ß can regulate vascular homeostasis by balancing the signaling between two distinct TGF-ß type I receptors (ie, the endothelial-restricted ALK1 and the broadly expressed ALK5 receptors). The activation of these receptors has been shown to induce opposite effects on endothelial cell behavior and angiogenesis. In this review, we will present recent advances in understanding the role of TGF-ß signaling in endothelial cells as well as the underlying molecular mechanisms by which perturbation of this pathway can lead to vascular disorders.

Key Words: angiogenesis • endothelial cells • hereditary hemorrhagic telangiectasia • Smad • transforming growth factor-ß




This article has been cited by other articles:


Home page
 JCBHome page
G. Ge and D. S. Greenspan
BMP1 controls TGF{beta}1 activation via cleavage of latent TGF{beta}-binding protein
J. Cell Biol., October 9, 2006; 175(1): 111 - 120.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2005 by the American College of Chest Physicians.